AI assistant
IONIS PHARMACEUTICALS INC — Director's Dealing 2014
Jan 3, 2014
30591_dirs_2014-01-03_71e60049-184a-4c74-ba27-bca381246fca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2014-01-01
Reporting Person: Geary Richard S (SVP, Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-01 | Common Stock | J | 164 | $24.1995 | Acquired | 3610 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-02 | Employee Stock Option (right to buy) | $39.87 | A | 45000 | Acquired | 2021-01-01 | Common Stock (45000) | Direct |
Footnotes
F1: Reporting 164 shares acquired under the Isis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on January 1, 2014. These 164 shares may not be sold until July 2, 2014.
F2: Grant of 1/2/14 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. 25% of the shares subject to the option vest and become exercisable on 1/2/15. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 11,250 shares per year. The option shall be fully vested and exercisable on 1/2/18. The option is exercisable as to 0 shares on 1/2/14.